The possible immunological mechanism to explain how interleukin-17 inhibitors can induce new onset inflammatory bowel disease. IFN, interferon; IL, interleukin; IL-17R, interleukin-17 receptor; TGF, transforming growth factor; TH17 cells, T helper 17 cells; TH1 cells, T helper 1 cells.